Crossmark Global Holdings’s Vericel Corp VCEL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-6,290
Closed -$268K 1350
2025
Q2
$268K Buy
+6,290
New +$262K ﹤0.01% 1151
2021
Q4
Sell
-9,800
Closed -$478K 1472
2021
Q3
$478K Sell
9,800
-540
-5% -$27.9K 0.01% 949
2021
Q2
$543K Sell
10,340
-450
-4% -$25.6K 0.01% 877
2021
Q1
$599K Buy
+10,790
New +$488K 0.01% 810

Other funds holding VCEL

Crossmark Global Holdings's VCEL Position: Q3 2025 in Review

Crossmark Global Holdings sold out of Vericel Corp (VCEL) in Q3 2025, closing a stake of 6,290 shares — an estimated $268K sold.

Crossmark Global Holdings first reported a position in VCEL in Q1 2021 and held it in 4 quarters. The position peaked at $599K in Q1 2021. 249 funds tracked by Wall St. Rank hold VCEL as of Q3 2025.

  • Crossmark Global Holdings reported no remaining Vericel Corp position as of Q3 2025 after selling out during the quarter.
  • Crossmark Global Holdings sold 6,290 Vericel Corp shares in Q3 2025, an estimated $268K.
  • Crossmark Global Holdings first reported a position in Vericel Corp in Q1 2021 and held it in 4 quarters.
  • Crossmark Global Holdings's Vericel Corp position peaked at $599K in Q1 2021.
  • 249 funds tracked by Wall St. Rank held Vericel Corp as of Q3 2025.

Based on Crossmark Global Holdings's 13F filing for Q3 2025, filed 12 Nov 2025.